Procyon Advisors LLC Cuts Stock Position in The Clorox Company (NYSE:CLX)

Posted by on Jun 21st, 2023

Procyon Advisors LLC lowered its position in The Clorox Company (NYSE:CLX – Get Rating) by 26.1% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,691 shares of the company’s stock after selling 1,306 shares during the period. Procyon Advisors LLC’s holdings in Clorox were worth $584,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Dark Forest Capital Management LP purchased a new position in shares of Clorox in the 4th quarter worth approximately $28,000. OLD Mission Capital LLC purchased a new position in shares of Clorox in the 4th quarter worth approximately $29,000. Delta Asset Management LLC TN purchased a new position in shares of Clorox in the 4th quarter worth approximately $31,000. Financial Avengers Inc. grew its position in shares of Clorox by 86.0% in the 4th quarter. Financial Avengers Inc. now owns 225 shares of the company’s stock worth $32,000 after buying an additional 104 shares during the last quarter. Finally, Koesten Hirschmann & Crabtree INC. purchased a new position in shares of Clorox in the 4th quarter worth approximately $35,000. Hedge funds and other institutional investors own 79.37% of the company’s stock.

Clorox Stock Performance

CLX opened at $155.47 on Wednesday. The company has a debt-to-equity ratio of 14.40, a current ratio of 0.87 and a quick ratio of 0.51. The firm has a fifty day moving average price of $162.23 and a 200 day moving average price of $154.00. The Clorox Company has a 1 year low of $122.65 and a 1 year high of $178.21. The stock has a market cap of $19.22 billion, a P/E ratio of 268.06, a P/E/G ratio of 2.79 and a beta of 0.30.

Clorox (NYSE:CLX – Get Rating) last posted its earnings results on Tuesday, May 2nd. The company reported $1.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.29. The firm had revenue of $1.92 billion during the quarter, compared to analysts’ expectations of $1.82 billion. Clorox had a net margin of 1.03% and a return on equity of 114.67%. The business’s revenue was up 5.9% compared to the same quarter last year. During the same period in the previous year, the business posted $1.31 EPS. Equities research analysts anticipate that The Clorox Company will post 4.48 earnings per share for the current year.

Analyst Ratings Changes

CLX has been the topic of several research analyst reports. StockNews.com initiated coverage on shares of Clorox in a research report on Thursday, May 18th. They set a “hold” rating on the stock. Bank of America boosted their target price on shares of Clorox from $130.00 to $140.00 in a research report on Wednesday, May 3rd. Barclays boosted their target price on shares of Clorox from $118.00 to $124.00 in a research report on Sunday, May 14th. Royal Bank of Canada boosted their target price on shares of Clorox from $137.00 to $151.00 in a research report on Wednesday, May 3rd. Finally, Wells Fargo & Company boosted their target price on shares of Clorox from $145.00 to $150.00 in a research report on Wednesday, May 3rd. Seven investment analysts have rated the stock with a sell rating, six have given a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $148.54.

Clorox Company Profile

(Get Rating)

The Clorox Co engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States.

See Also

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Get Rating).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.